Xencor | XNCR - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
AbbVie USD 6.57B 2.82B 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Biogen USD 1.28B 2.1B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cytokinetics USD 255.27M 125.43M 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
J&J USD 20.42B 1.27B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
MacroGenics USD 113.91M 47.39M 2026-06
Merck USD 6.85B 1.52B 2026-06
Novartis USD 7.62B 739M 2026-06
Pfizer USD 976M 727M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Xencor USD 44.66M 30.49M 2026-06